Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis.

Sakamachi Y, Wiley E, Solis A, Johnson CG, Meng X, Hussain S, Lipinski JH, O'Dwyer DN, Randall T, Malphurs J, Papas B, Wu BG, Li Y, Kugler M, Mehta S, Trempus CS, Thomas SY, Li JL, Zhou L, Karmaus PW, Fessler MB, McGrath JA, Gibson K, Kass DJ, Gleiberman A, Walts A, Invernizzi R, Molyneaux PL, Yang IV, Zhang Y, Kaminski N, Segal LN, Schwartz DA, Gudkov AV, Garantziotis S. Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis. bioRxiv. 2024 Apr 30.

View in: PubMed

collapse authors with profiles


Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)